USPTO serial 79416327
ICEM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 28, 2026
- Examiner
- TENG, SIMON
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ICEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anne Wang
Anne Wang FBT Gibbons LLP301 East Fourth Street3300 Great American TowerCincinnati, OH 45202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; electronic medical apparatus for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical diagnostic devices and instruments for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical devices and instruments for monitoring and treating health and medical conditions, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; medical implants made of artificial materials for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; wearable medical devices for use in the diagnosis, monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; apparatus for use in the diagnosis, monitoring and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; sensors being measurement apparatus for medical use, namely, the monitoring, management and treatment of neurological conditions and central nervous system disorders, namely, epilepsy, seizure control, sleep apnea, sleep disorders, psychosis, dementia, Alzheimer's disease and for brain machine interfacing, namely, neural control of artificial limb prosthetics; none of the aforementioned goods being syringes; electrodes for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Epiminder Limited
- Other trademarks owned by Epi-Minder Pty Ltd
- Other trademarks owned by Epiminder Limited
- Other trademarks owned by Epiminder Limited
- Other trademarks in Class 010
- Similar marks named ICEM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 23, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 6, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 5, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 28, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 28, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 10, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 10, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 5, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 18, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 17, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 10, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 10, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 10, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 10, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 10, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 22, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 13, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 13, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 13, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 13, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 13, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 22, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 29, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 29, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 11, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 10, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |